Stay updated with breaking news from Jerry niederkorn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Posted on 553 Aviceda Therapeutics, a late-stage, pre-clinical biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology to manipulate the innate immune system and chronic, non-resolving inflammation, is announcing the composition of the Executive Team that will guide the company through ongoing development of breakthrough, first-in-class therapeutics and continued growth opportunities as a business entity. Serving in key leadership roles on Aviceda’s Executive Leadership Team will be: Mohamed Genead, MD, CEO & President, David Callanan, MD, Chief Medical Officer, Derek Kunimoto, MD, JD, Chief Operating Officer, Michael Tolentino, MD, Chief Technology Officer, and Christopher Scott, PhD, Chief Scientific Officer. ....